All In MedTech

FDA Clearance Tracker · K173352

Trevo Pro Vue Retriever and Trevo XP Pro Vue Retriever (Trevo Retriever)

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Feb 15, 2018 (this decision)Source: openFDAMethods & limitations

510(k)Breakthrough

Decided

Feb 15, 2018

Substantially Equivalent

Time to decision

113 days

Received Oct 25, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K173352
Device name
Trevo Pro Vue Retriever and Trevo XP Pro Vue Retriever (Trevo Retriever)
Applicant location
Mountain View, CA
Received
Oct 25, 2017
Decided
Feb 15, 2018
Decision
Substantially Equivalent
Submission type
Traditional
Expedited review
Yes, flagged as expedited in FDA's record.

Device type

Device class
Class II
Regulation
21 CFR 882.5600

Every decision under product code POL

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code POL. The earliest in FDA's data is DEN150049, decided Sep 2, 2016.
  • It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Concentric Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.